Initially misleading communication of carrier results after newborn genetic screening

Alison La Pean1, Michael H Farrell

  • 1Neurogenetics Branch, National Institutes of Health/National Institute of Neurological Disorders and Stroke, Bethesda, Maryland, USA.

Pediatrics
|December 3, 2005
PubMed

Insights

Newborn screening communication often misleads parents about their infant's carrier status for conditions like sickle cell hemoglobinopathy (SCH) and cystic fibrosis (CF). Improving how results are delivered is crucial for parental understanding and adherence to care.

Area of Science:

  • Medical Genetics
  • Pediatric Screening
  • Communication in Healthcare

Background:

  • Newborn screening is vital for early detection of genetic disorders, but effective communication of results significantly impacts parental understanding and treatment adherence.
  • Initial communication of positive screening results, particularly for carrier status of sickle cell hemoglobinopathy (SCH) and cystic fibrosis (CF), is critical for avoiding psychosocial distress.
  • This study defines and investigates 'initially misleading' communication, characterized by the premature delivery of negative information before positive or neutral findings.

Purpose of the Study:

  • To determine the prevalence of initially misleading communication in counseling sessions following newborn genetic screening for SCH and CF.
  • To analyze the nature and extent of misleading statements and the time delay before clarification of results.

Main Methods:

  • A quantitative, explicit-criteria method was employed to analyze 59 transcribed counseling conversations between pediatric residents and standardized parents.
  • Transcripts were evaluated for the presence and order of 'bad-news' and 'good-news' content items related to infant carrier status.

Main Results:

  • A high prevalence of initially misleading communication was observed, with 41 out of 59 (69.5%) transcripts containing negative statements before positive or neutral ones.
  • Misleading communication was significantly more common in likely cystic fibrosis (CF) carrier cases (89.7%) compared to sickle cell hemoglobinopathy (SCH) carrier cases (50%).
  • On average, misleading transcripts contained 5.5 misleading statements, with a significant delay of 28.1 statements before the first good-news statement was delivered.

Conclusions:

  • The high frequency of misleading communication and delayed clarification poses a significant barrier to parental comprehension of infant carrier status.
  • Enhancements in training curricula for healthcare providers and robust quality assurance measures are essential to improve parental understanding and public confidence in genetic screening.
  • Addressing communication deficits is paramount for optimizing outcomes in newborn screening programs and alleviating parental anxiety.
Abstract